ArticleGland surgery2025

The impact of serum interleukin-17a as a predictive biomarker for neoadjuvant therapy response in breast cancer: a retrospective study.

Liyan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.